Both in Biotechnology
Entera Bio vs Candel Therapeutics
Over the past year ENTX returned +12.7% and CADL returned +59.6%; their daily moves had a correlation of 0.18.
ENTX +12.7% CADL +59.6%Growth of $1, one year, split-adjusted
| Metric | ENTX | CADL |
|---|---|---|
| Price | $3.20 | $8.33 |
| Market cap | $556.6M | $637.4M |
| Today | +2.56% | −3.70% |
| 1 month | +10.7% | −18.0% |
| 6 months | +190.9% | +28.7% |
| Year to date | +64.9% | +47.4% |
| 1 year | +17.2% | +51.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $11.0M | $153.7M |
| Dividend yield | — | — |
| Volatility (60d) | 61.9% | 65.1% |
| Short % of float | 3.5% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).